We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+8.4%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$149B
AUM Growth
+$5.43B
(+3.8%)
Cap. Flow
-$4.27B
Cap. Flow
% of AUM
-2.87%
Top 10 Holdings %
Top 10 Hldgs %
30.32%
Holding
338
New
11
Increased
51
Reduced
229
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$151M |
| 2 |
Alibaba
BABA
|
+$115M |
| 3 |
XPeng
XPEV
|
+$79M |
| 4 |
Raymond James Financial
RJF
|
+$71.4M |
| 5 |
Allogene Therapeutics
ALLO
|
+$64.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$285M |
| 2 |
NetApp
NTAP
|
+$236M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$220M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$209M |
| 5 |
Adobe
ADBE
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.47% |
| 2 | Healthcare | 26.97% |
| 3 | Industrials | 12.32% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Financials | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Autodesk
ADSK
$52.6B
| $177M | 0.12% |
608,000
-1,900
| -0.3% | -$542K |
|
127
Teradyne
TER
$59.3B
| $177M | 0.12% |
1,320,930
-90,045
| -6% | -$11.5M |
|
128
DuPont de Nemours
DD
$19.2B
| $173M | 0.12% |
1,785,492
-25,524
| -1% | -$2.56M |
|
129
Ametek
AME
$58.2B
| $173M | 0.12% |
1,294,540
-6,800
| -0.5% | -$911K |
|
130
Progressive
PGR
$125B
| $168M | 0.11% |
1,711,900
-31,310
| -2% | -$3.1M |
|
131
Alkermes
ALKS
$8.25B
| $161M | 0.11% |
6,558,420
-112,070
| -2% | -$2.49M |
|
132
Dow Inc
DOW
$21.2B
| $158M | 0.11% |
2,496,335
-19,962
| -0.8% | -$1.32M |
|
133
WEX
WEX
$6.31B
| $155M | 0.1% |
799,764
+233,414
| +41% | +$47.9M |
|
134
Newell Brands
NWL
$2.56B
| $153M | 0.1% |
5,568,800
-478,150
| -8% | -$13.2M |
|
135
Chegg
CHGG
$102M
| $152M | 0.1% |
1,829,700
-47,800
| -3% | -$3.96M |
|
136
IQVIA
IQV
$39.3B
| $147M | 0.1% |
606,877
-3,970
| -0.6% | -$917K |
|
137
HubSpot
HUBS
$10.5B
| $146M | 0.1% |
249,992
-6,500
| -3% | -$3.39M |
|
138
Marriott International
MAR
$92.3B
| $139M | 0.09% |
1,019,046
-15,050
| -1% | -$2.17M |
|
139
Otis Worldwide
OTIS
$28.2B
| $137M | 0.09% |
1,675,448
-11,650
| -0.7% | -$897K |
|
140
CSX Corp
CSX
$93.1B
| $136M | 0.09% |
4,232,400
-534,900
| -11% | -$17.6M |
|
141
Charles River Laboratories
CRL
$12.8B
| $135M | 0.09% |
365,510
-4,750
| -1% | -$1.59M |
|
142
Dollar Tree
DLTR
$25.2B
| $134M | 0.09% |
1,350,850
+332,350
| +33% | +$36.1M |
|
143
Nutanix
NTNX
$16.9B
| $133M | 0.09% |
3,491,885
+48,400
| +1% | +$1.51M |
|
|
EA
144
DELISTED
Electronic Arts
EA
| $129M | 0.09% |
898,975
-14,350
| -2% | -$2.04M |
|
|
EPZM
145
DELISTED
Epizyme, Inc
EPZM
| $127M | 0.09% |
15,287,477
+50,350
| +0.3% | +$424K |
|
146
Stryker
SYK
$130B
| $123M | 0.08% |
475,000
-3,400
| -0.7% | -$869K |
|
147
Rhythm Pharmaceuticals
RYTM
$7.96B
| $120M | 0.08% |
6,153,691
+148,098
| +2% | +$3.08M |
|
148
Freeport-McMoran
FCX
$97.5B
| $120M | 0.08% |
3,221,400
-310,400
| -9% | -$12.1M |
|
149
FormFactor
FORM
$9.17B
| $117M | 0.08% |
3,208,892
-127,767
| -4% | -$5.04M |
|
150
Pinterest
PINS
$13.4B
| $117M | 0.08% |
1,479,200
-81,600
| -5% | -$5.69M |
|
Similar funds
VAM
Primecap Management's Q2 2021 Portfolio in Review
As of Q2 2021, Primecap Management held 338 positions worth $149B, up 3.8% from $143B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 4.7%. Primecap Management opened 11 new positions and exited 5, leaving the 338-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q2 2021 buy was Xometry: 300,000 shares worth $26.2M.
- Primecap Management added most to Splunk Inc in Q2 2021, an estimated $151M increase.
- Primecap Management's biggest Q2 2021 reduction was Eli Lilly, cutting an estimated $285M.
- Primecap Management fully exited Perspecta Inc. Common Stock in Q2 2021, selling an estimated $16.9M.
- Primecap Management's ten largest holdings make up 30% of its $149B portfolio in Q2 2021.
- Primecap Management opened 11 new positions and closed 5 in Q2 2021.
- Primecap Management's portfolio value rose 3.8% quarter-over-quarter to $149B.
Based on Primecap Management's 13F filing for Q2 2021, filed 10 Aug 2021.